companydata.dkNovo Nordisk Denmark A/S: Financial statements 2022
CVR: 38180045
Novo Nordisk Denmark A/S (CVR 38180045) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 509,919,862 and a net result of DKK 33,547,904 compared with DKK 21,405,179 the year before. That is an increase of 36.4% compared with the year before. The profit margin was 6.6%. Equity amounted to DKK 49,140,448. The solvency ratio was 11%. The company had 200 employees in the financial year.
- Revenue
- 509,919,862 kr.
- Gross Profit
- 333,172,771 kr.
- Profit/Loss
- 33,547,904 kr.
- Equity
- 49,140,448 kr.
- Total Assets
- 446,733,824 kr.
- Employees
- 200
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 509.9 mio. | 333.2 mio. | 33.5 mio. | 49.1 mio. | 200 |
| 2021 | 373.9 mio. | 311.9 mio. | 21.4 mio. | 37 mio. | 176 |
| 2020 | 330.1 mio. | 276.1 mio. | 21.3 mio. | 36.6 mio. | 152 |
| 2019 | 363.9 mio. | 134.9 mio. | 5.3 mio. | 15.3 mio. | 65 |
| 2018 | 341.9 mio. | 119.2 mio. | 4.2 mio. | 10.1 mio. | 69 |
Keep an eye on Novo Nordisk Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 26, 2022, Jonas Emil Kongshøj Larsen has joined the board of directors of Novo Nordisk Denmark A/S.
As of October 26, 2022, Frederik Kier has left the board of directors of Novo Nordisk Denmark A/S.
As of October 26, 2022, Jeppe Theisen is registered as director of Novo Nordisk Denmark A/S.
As of October 26, 2022, Kasper Bødker Mejlvang has stepped down as director of Novo Nordisk Denmark A/S.
Novo Nordisk Denmark A/S has published its annual report for 2021. Revenue came to DKK 373,940,044, and the net result was DKK 21,405,179.
About Novo Nordisk Denmark A/S
Novo Nordisk Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Novo Nordisk Region Europe Pharmaceuticals A/S. The management consists of Mads Wilhelm Øckenholt Larsen. The company is owned by NOVO NORDISK REGION EUROPE A/S. The company has 81 employees. In 2025, the company reported revenue of DKK 2,504,841,000 and a net result of DKK 118,803,000 compared with DKK 86,129,000 the year before. Equity amounted to DKK 134,570,000.